Vissapragada R, Bulamu NB, Whiteman DC, Bright T, Karnon J, Watson DI. Computing lifetime incidence of esophageal adenocarcinoma and age-specific prevalence of Barrett’s esophagus. Dis Esophagus. 2025;38:doaf038.
Article PubMed PubMed Central Google Scholar
Cook MB, Coburn SB, Lam JR, Taylor PR, Schneider JL, Corley DA. Cancer incidence and mortality risks in a large US Barrett’s oesophagus cohort. Gut. 2018;67:418–529.
Anderson LA, Murray LJ, Murphy SJ, Fitzpatrick DA, Johnston BT, Watson RG et al. Mortality in Barrett’s oesophagus: results from a population based study. Gut. 2003;52:1081–1084.
Article CAS PubMed PubMed Central Google Scholar
Dam AN, Klapman J. A narrative review of Barrett’s esophagus in 2020, molecular and clinical update. Ann Transl Med. 2020;8:1107.
Article CAS PubMed PubMed Central Google Scholar
Rice TW, Rusch VW, Ishwaran H, Blackstone EH. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer 2010;116:37–73.
Mohapatra S, Al Ghamdi SS, Charilaou P, Lopimpisuth C, Das A, Ngamruengphong S. Predictors for lymph node metastasis and survival of patients with T1b esophageal adenocarcinoma treated with surgery and endoscopic therapy: an analysis of the Surveillance, Epidemiology, and End Results database. Gastrointest Endosc. 2024;100:849–856.
Dubecz A, Kern M, Solymosi N, Schweigert M, Stein HJ. Predictors of lymph node metastasis in surgically resected T1 esophageal cancer. Ann Thorac Surg. 2015;99:1879–1886.
Gockel I, Sgourakis G, Lyros O, Polotzek U, Schimanski CC, Lang H et al. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. Expert Rev Gastroenterol Hepatol. 2011;5:371–384.
Thosani N, Singh H, Kapadia A, Ochi N, Lee JH, Ajani J et al. Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis. Gastrointest Endosc. 2012;75:242–253.
Qumseya B, Sultan S, Bain P, Jamil L, Jacobson B, Anandasabapathy S et al. ASGE guideline on screening and surveillance of Barrett’s esophagus. Gastrointest Endosc. 2019;90:335–59.e2.
Pimentel-Nunes P, Libânio D, Bastiaansen BAJ, Bhandari P, Bisschops R, Bourke MJ et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022. Endoscopy. 2022;54:591–622.
Gupta S, Mandarino FV, Shahidi N, Hourigan LF, Messmann H, Wallace MB et al. Can optical evaluation distinguish between T1a and T1b esophageal adenocarcinoma: an international expert interobserver agreement study. Endoscopy. 2025;57:200–207.
Younis F, Rösch T, Beyna T, Ebigbo A, Faiss S, May A et al. Expert assessment of infiltration depth and recommendation of endoscopic resection technique in early Barrett cancer. United European Gastroenterol J. 2024;12:848–858.
Article CAS PubMed PubMed Central Google Scholar
Ebigbo A, Mendel R, Rückert T, Schuster L, Probst A, Manzeneder J et al. Endoscopic prediction of submucosal invasion in Barrett’s cancer with the use of artificial intelligence: a pilot study. Endoscopy. 2021;53:878–883.
Qumseya BJ, Brown J, Abraham M, White D, Wolfsen H, Gupta N et al. Diagnostic performance of EUS in predicting advanced cancer among patients with Barrett’s esophagus and high-grade dysplasia/early adenocarcinoma: systematic review and meta-analysis. Gastrointest Endosc. 2015;81:865–74.e2.
Nabi Z, Mohapatra S, Uedo N, Mohapatra A, Inavolu P, Rughwani H et al. Image-enhanced endoscopy in upper GI tract: State-of-the-art review. Indian J Gastroenterol. 2025. https://doi.org/10.1007/s12664-025-01850-z.
Seifert H, Fusaroli P, Arcidiacono PG, Braden B, Herth F, Hocke M et al. Controversies in EUS: Do we need miniprobes? Endosc Ultrasound. 2021;10:246–269.
Article PubMed PubMed Central Google Scholar
Peters FP, Brakenhoff KPM, Curvers WL, Rosmolen WD, Fockens P, ten Kate FJW et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett’s esophagus. Gastrointest Endosc. 2008;67:604–609.
Yamasaki A, Shimizu T, Kawachi H, Yamamoto N, Yoshimizu S, Horiuchi Y et al. Endoscopic features of esophageal adenocarcinoma derived from short-segment versus long-segment Barrett’s esophagus. J Gastroenterol Hepatol. 2020;35:211–217.
Gupta S, Rai M, Bechara R. Morphologic and histopathologic evaluation of Barrett’s esophagus neoplasia from 94 endoscopic submucosal dissection specimens. Gastrointest Endosc. 2025;101:S450.
Forbes N, Elhanafi SE, Al-Haddad MA, Thosani NC, Draganov PV, Othman MO et al. American Society for gastrointestinal endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendations. Gastrointest Endosc. 2023;98:271–284.
Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–536.
Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58:882–893.
Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I. The case of the misleading funnel plot. BMJ. 2006;333:597–600.
Article PubMed PubMed Central Google Scholar
Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ. 2004;329:168–169.
Article PubMed PubMed Central Google Scholar
Pech O, Gossner L, Manner H, May A, Rabenstein T, Behrens A et al. Prospective evaluation of the macroscopic types and location of early Barrett’s neoplasia in 380 lesions. Endoscopy. 2007;39:588–593.
Article CAS PubMed Google Scholar
Ikenoyama Y, Namikawa K, Takamatsu M, Kumazawa Y, Tokai Y, Yoshimizu S et al. Long- vs short-segment Barrett’s esophagus-derived adenocarcinoma: clinical features and outcomes of endoscopic submucosal dissection. Surg Endosc. 2024;38:3636–3644.
Scotiniotis IA, Kochman ML, Lewis JD, Furth EE, Rosato EF, Ginsberg GG. Accuracy of EUS in the evaluation of Barrett’s esophagus and high-grade dysplasia or intramucosal carcinoma. Gastrointest Endosc. 2001;54:689–696.
Article CAS PubMed Google Scholar
Buskens CJ, Westerterp M, Lagarde SM, Bergman JJ, ten Kate FJ, van Lanschot JJ. Prediction of appropriateness of local endoscopic treatment for high-grade dysplasia and early adenocarcinoma by EUS and histopathologic features. Gastrointest Endosc. 2004;60:703–710.
Larghi A, Lightdale CJ, Memeo L, Bhagat G, Okpara N, Rotterdam H. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett’s esophagus. Gastrointest Endosc. 2005;62:16–23.
Mino-Kenudson M, Brugge WR, Puricelli WP, Nakatsuka LN, Nishioka NS, Zukerberg LR et al. Management of superficial Barrett’s epithelium-related neoplasms by endoscopic mucosal resection: clinicopathologic analysis of 27 cases. Am J Surg Pathol. 2005;29:680–686.
Pech O, May A, Günter E, Gossner L, Ell C. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett’s esophagus. Am J Gastroenterol. 2006;101:2223–2229.
Prasad GA, Buttar NS, Wongkeesong LM, Lewis JT, Sanderson SO, Lutzke LS et al. Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett’s esophagus. Am J Gastroenterol. 2007;102:2380–2386.
Comments (0)